To investigate the role of astrocytic SNAT-3 in depression, pAAV.GFAP.Cre.WPRE.hGH and pAAV2.pX552ch-sgSlc38a3 were co-injected into CRISPR/CAS9-EGFP mice (Fig. 3A). Here, GFAP is linked to depressive disorder.